Literature DB >> 13355946

Keratoconjunctivitis sicca and the collagen diseases.

W F KINNEAR, J H RAMAGE.   

Abstract

Entities:  

Keywords:  COLLAGEN DISEASES/manifestations; KERATOCONJUNCTIVITIS

Mesh:

Year:  1956        PMID: 13355946      PMCID: PMC1324664          DOI: 10.1136/bjo.40.7.416

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  10 in total

1.  Observations on the pathology of Sjögren's syndrome.

Authors:  B S CARDELL; K J GURLING
Journal:  J Pathol Bacteriol       Date:  1954-07

2.  Sjogren's syndrome.

Authors:  K MACLEAN; H S ROBINSON
Journal:  Can Med Assoc J       Date:  1954-12       Impact factor: 8.262

3.  The probable systemic nature of Mikulicz's disease and its relation to Sjögren's syndrome.

Authors:  W S MORGAN
Journal:  N Engl J Med       Date:  1954-07-01       Impact factor: 91.245

4.  Cortisone and corticotropin (ACTH) in treatment of scleroderma.

Authors:  R R KIERLAND; E A HINES
Journal:  AMA Arch Derm Syphilol       Date:  1951-11

5.  The effect of cortisone on the lesions of periarteritis nodosa.

Authors:  A H BAGGENSTOSS; R M SHICK; H F POLLEY
Journal:  Am J Pathol       Date:  1951 Jul-Aug       Impact factor: 4.307

6.  ACTH and cortisone in diffuse collagen disease and chronic dermatoses; differential therapeutic effects.

Authors:  E N IRONS; J P AYER; R G BROWN; S H ARMSTRONG
Journal:  J Am Med Assoc       Date:  1951-03-24

7.  Effects of cortisone on acute disseminated lupus erythematosus.

Authors:  L A BRUNSTING; C H SLOCUMB; J W DIDCOCT
Journal:  AMA Arch Derm Syphilol       Date:  1951-01

8.  Polyarteritis nodosa: a clinical and pathological study and report of 6 cases.

Authors:  M H ROSE; D LITTMANN; J HOUGHTON
Journal:  Ann Intern Med       Date:  1950-06       Impact factor: 25.391

9.  RAYNAUD'S DISEASE, THROMBO-ANGIITIS OBLITERANS AND SCLERODERMA: SELECTION OF CASES FOR AND RESULTS OF SYMPATHETIC GANGLIONECTOMY AND TRUNK RESECTION.

Authors:  W J Mayo; A W Adson
Journal:  Ann Surg       Date:  1932-10       Impact factor: 12.969

10.  The riddle of sarcoidosis: Hutchinson-Boeck granulomatosis.

Authors:  W S MIDDLETON
Journal:  Ann Intern Med       Date:  1954-09       Impact factor: 25.391

  10 in total
  13 in total

1.  A broader spectrum of Sjogren's syndrome and its pathogenetic implications.

Authors:  J J BUNIM
Journal:  Ann Rheum Dis       Date:  1961-03       Impact factor: 19.103

2.  ANTINUCLEAR AND PRECIPITATING AUTO-ANTIBODIES IN SJOEGREN'S SYNDROME.

Authors:  J S BECK; J R ANDERSON; K J BLOCH; W W BUCHANAN; J J BUNIM
Journal:  Ann Rheum Dis       Date:  1965-01       Impact factor: 19.103

3.  [Sjogren's syndrome with extensive skin phenomena].

Authors:  P RITZENFELD
Journal:  Arch Klin Exp Dermatol       Date:  1962-11-12

4.  Sjögren's syndrome and systemic lupus erythematosus.

Authors:  J M HEATON
Journal:  Br Med J       Date:  1959-02-21

5.  The pathology of Mikulicz-Sjogren disease in relation to disseminated lupus erythematosus. A review of the autopsy findings and presentation of a case.

Authors:  G O BAIN
Journal:  Can Med Assoc J       Date:  1960-01-16       Impact factor: 8.262

6.  Keratoconjunctivitis sicca due to sarcoidosis.

Authors:  B R JONES; C J STEVENSON
Journal:  Br J Ophthalmol       Date:  1957-03       Impact factor: 4.638

7.  [Serum protein studies in scleroderma and Sjögren syndrome].

Authors:  E OBLATT; L FEHER; T CSIKY
Journal:  Klin Wochenschr       Date:  1958-08-15

8.  Sjögren's syndrome in relation to pernicious anaemia and idiopathic Addison's disease.

Authors:  J Williamson; R W Paterson; D D McGavin; W R Greig; K Whaley
Journal:  Br J Ophthalmol       Date:  1970-01       Impact factor: 4.638

9.  Cell-mediated immunity in Sjögren's syndrome.

Authors:  H Berry; P A Bacon; J D Davis
Journal:  Ann Rheum Dis       Date:  1972-07       Impact factor: 19.103

10.  Scleroderma and Sjögren's syndrome.

Authors:  T H Kirkham
Journal:  Br J Ophthalmol       Date:  1969-02       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.